Hydrogen and Fatigue: What the Research Reports

Posted on July 23, 2026

The most closely watched fatigue trial in molecular hydrogen research right now didn't come out of an exercise physiology lab. It came out of a Long-COVID clinic. That's a meaningful shift. For more than a decade, "hydrogen and fatigue" mostly meant athletes and lactate — sprint intervals, recovery drinks, shaved seconds off a time trial. The newer studies are asking a different question entirely: can hydrogen-rich water do anything for the kind of fatigue that doesn't go away with a good night's sleep?

That question matters because chronic, low-grade fatigue is one of the most common reasons people search for anything related to wellness in the first place. Not the tired-after-a-workout kind. The kind that follows a viral illness for months. The kind that defines myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a condition with essentially no FDA-approved treatments. Researchers have started testing hydrogen-rich water in exactly these populations over the past two years, and the pattern in the data is worth walking through carefully — including the parts that didn't work on the first try.

What makes this research thread worth following closely is that it reads like real science in motion — a research team ran a trial, learned from it, adjusted the dose and duration, and got a clearer result the second and third time. That kind of iterative refinement is how a signal gets separated from noise, and it's why the most recent trials in this area carry more weight than the earliest one.

Why Fatigue Is the Question Hydrogen Water Research Keeps Circling Back To

Fatigue shows up constantly in molecular hydrogen research, but it rarely gets its own headline. It's usually a secondary measure buried in a table — a footnote to a cholesterol trial, an aside in a cardiovascular study. That's changing. Since 2022, several research groups have made fatigue the primary outcome, not an afterthought, and pointed the studies at populations where fatigue is the actual clinical problem: Long-COVID patients, and people living with ME/CFS.

This is a genuinely different research thread than the exercise-recovery literature we have covered before in our piece on hydrogen water for athletes and our muscle recovery research roundup. Those trials measure fatigue as a training variable — something that spikes after a workout and resolves with rest. The newer trials measure fatigue as a persistent, disabling condition. Different populations, different endpoints, and — this is the part that makes the research interesting — a mechanism researchers think might apply to both.

It also connects to work we have already covered on hydrogen water and inflammation and hydrogen water and brain health. Fatigue, inflammation, and the kind of cognitive fog people describe as "brain fog" tend to travel together clinically — they share overlapping biological pathways, which is part of why researchers studying one condition keep an eye on the others. Understanding hydrogen's proposed role in fatigue specifically fills in a piece of that broader picture.

What "Fatigue" Actually Measures in a Clinical Trial

"Fatigue" sounds vague. In these trials, it isn't. Researchers use validated instruments — the Fatigue Severity Scale, the SF-36 Physical Function subscale, six-minute walk tests, grip strength — specifically because self-reported tiredness alone is too slippery to build a trial around. A study has to show movement on at least one of these instruments, ideally more than one, before researchers will say anything moved at all.

Subjective Scores vs. Objective Function

This distinction matters more than it sounds like it should. A questionnaire score can shift for reasons that have nothing to do with the intervention — expectation, attention from researchers, the placebo response is real and well documented. A six-minute walk test is harder to fake. When a trial reports improvement on both a self-report scale and an objective function measure, that's a stronger signal than either alone. Keep that distinction in mind as we walk through the specific trials below — some report only subjective improvement, others report both, and that difference is exactly why researchers keep running more trials instead of declaring the question settled.

There's also a biological layer underneath the questionnaires. Several of the trials below track salivary or serum biomarkers alongside the self-report scores — C-reactive protein as a marker of systemic inflammation, uric acid as a marker of antioxidant status, interleukin-6 as a marker of the inflammatory cascade researchers think drives post-viral fatigue in particular. None of these biomarkers alone proves hydrogen water changed how someone feels day to day. But when a biomarker moves in the same direction as a fatigue score, in the same trial, at the same time, that's the kind of convergent evidence that makes a finding harder to wave away as noise.

The Mitochondrial Case for Hydrogen and Energy

Why would a gas dissolved in drinking water plausibly affect fatigue at all? The mechanistic argument researchers have proposed centers on mitochondria — the cellular structures that generate the ATP your body actually runs on. Hirano et al. (2022), writing in Frontiers in Neurology, laid out the case in a literature review specific to ME/CFS: mitochondrial dysfunction is a consistently observed feature of the condition, and molecular hydrogen has been reported to selectively neutralize hydroxyl radicals — one of the most damaging reactive oxygen species generated during cellular energy production. The review's argument is that if excess hydroxyl radical activity is contributing to the mitochondrial dysfunction seen in ME/CFS, a selective antioxidant that reaches those radicals without disrupting normal signaling is a plausible candidate to study.

Selective Antioxidant, Not Broad Suppression

This selectivity is the whole argument, and it's worth being precise about it. Ohsawa et al. (2007) first reported in Nature Medicine that hydrogen appeared to target hydroxyl radicals specifically rather than acting as a broad-spectrum antioxidant that suppresses reactive oxygen species indiscriminately. That distinction matters because some ROS signaling is beneficial — cells use it for adaptation and repair. A blunt antioxidant risks interfering with that. A selective one, in theory, doesn't. Hirano and colleagues extended that logic to ME/CFS specifically, framing hydrogen's proposed selectivity as the reason it might address fatigue-related mitochondrial stress without the trade-offs of more aggressive antioxidant approaches. A proposed mechanism. Not proof of a clinical effect — that requires trials in actual patients, which is where the last two years of research have focused.

There's a second piece to the mitochondrial argument that's easy to skip past: dose and duration appear to matter more than researchers initially assumed. A single glass of hydrogen-rich water produces a transient rise in dissolved hydrogen that clears the body within roughly an hour or two — hydrogen doesn't accumulate the way a fat-soluble compound might. That pharmacokinetic reality is part of why the ME/CFS research program (discussed in detail below) shifted toward longer, more consistent daily intake rather than a single large dose. If the proposed mechanism is real, it's a repeated, cumulative signal to mitochondria over weeks — not a one-time antioxidant hit.

Long COVID Fatigue: The Clearest Recent Signal

The single clearest recent data point comes from Long-COVID research, not ME/CFS research — though the two conditions share enough biological overlap that findings in one inform hypotheses in the other. It's part of a wider pattern across post-viral recovery generally, and what the hydrogen trials in post-viral recovery found spans everything from a six-minute walk test gain to a trial run during active infection itself.

A 14-Day Trial in 32 Adults

Tan et al. (2024), publishing in Nutrients, ran a pilot, single-blind, randomized, controlled trial in adults with Long-COVID. Thirty-two eligible participants were split into a hydrogen-rich water group and a placebo-water group, each drinking their assigned water for 14 consecutive days. The researchers tracked fatigue severity, six-minute walk test distance, grip strength, and sleep quality — a mix of subjective and objective measures, which is exactly the combination that makes a fatigue trial worth taking seriously.

The hydrogen-rich water group showed significantly reduced fatigue scores and significantly improved distance covered on the six-minute walk test compared to placebo. Muscle strength and sleep quality both moved in the favorable direction as well. It was a 14-day, single-blind pilot in 32 people; the result has not been replicated.

What Improved, and What Didn't

Here's the honest part, and it's a good example of why we report on studies instead of overselling them: the same trial found no significant improvement in dyspnea, the shortness-of-breath symptom that's often the most disruptive part of Long-COVID for patients. Researchers noted this as an important nuance rather than a failure — fatigue and dyspnea appear to respond differently, which tells future trial designers something useful about which symptoms to target and how. Tan and colleagues framed the partial response pattern as exactly the kind of finding that should shape the next generation of trials, not as a verdict either way.

Chronic Fatigue Syndrome: Three Trials, One Research Team, A Clear Trend

ME/CFS research on hydrogen water has moved through three developmental trials, all run by the same investigative team at Stony Brook University, led by Fred Friedberg. Friedberg and LeBaron (2026), reviewing all three in Frontiers in Medicine, describe a research program that adjusted its approach after each result — which is what good clinical research is supposed to do.

The First Attempt Didn't Work — Here's What Changed

The initial trial used an aggressive schedule: up to five glasses of hydrogen-rich water daily for 28 days. It didn't separate from placebo on fatigue or the biological markers researchers tracked. Some participants also reported adverse effects at that dose. Rather than concluding hydrogen wasn't worth pursuing, the research team did what disciplined researchers do — they lowered the dose, extended the observation period, and tried again. That's not a footnote to bury. It's the reason the next two trials look the way they do, and it's a better story about how real science works than a single clean win would have been.

The 2026 Verdict

The follow-up 8-week pilot trial, reported by Friedberg and Choi (2025) in Fatigue: Biomedicine, Health & Behavior, randomized 39 participants across three arms — hydrogen water, app-based heart rate variability biofeedback, and a combined condition — and found small but statistically significant pre-to-post improvements in the Fatigue Severity Scale and the SF-36 Physical Function subscale in the hydrogen water group, with side effects that were milder and less frequent than in the first attempt. A subsequent 16-week, home-based trial extended the finding further: both a standard-dose group and a dose-escalation group showed statistically significant, clinically relevant improvements in fatigue and physical function, with the standard-dose group also showing additional benefit on depression and anxiety measures. Friedberg and LeBaron's 2026 review concludes that moderate-dose hydrogen-rich water, taken consistently over extended periods, has demonstrated feasibility and preliminary changes in ME/CFS fatigue and physical-function scores. All three trials are small pilots from a single research group, and larger independent trials have not yet been published.

Exercise Fatigue: The Deeper Research Base

None of this happens in a vacuum. The chronic-illness trials sit on top of a much larger body of exercise-fatigue research that's been accumulating since the early 2010s — the research base we have covered in more depth in our muscle recovery article.

A Meta-Analysis of 19 Trials

Ostojic and colleagues (2024), publishing a systematic review and meta-analysis in Frontiers in Nutrition, pooled 19 clinical trials covering 402 participants and found that hydrogen supplementation was associated with roughly a 38% reduction in perceived exertion and a roughly 42% reduction in blood lactate during exercise. The authors were careful to flag heterogeneity across study designs, hydrogen doses, and training status as real limitations — and called for standardized protocols going forward. Nineteen trials pointing in a consistent direction on perceived exertion is the backdrop against which the newer, much smaller chronic-illness trials should be read.

A separate randomized crossover study adds a useful data point on delivery method. Dong et al. (2024), publishing in the International Journal of Sports Medicine, had 24 healthy men inhale hydrogen-rich gas before a sustained cycling test and found reduced subjective fatigue, better sustained performance, and lower serum lactate compared to the control condition. It's a single-session, acute finding — not a chronic-fatigue trial — but it reinforces that the fatigue-reduction signal shows up across more than one delivery method and more than one research group, which is exactly the kind of convergent replication that separates a durable finding from a one-off result.

Frequently Asked Questions

Is hydrogen water a treatment for chronic fatigue syndrome or Long COVID?

No. Hydrogen water is not a medical treatment, and none of the trials described above position it as a replacement for medical care. They're small, early-stage pilot studies in a research area with few options studied, and they remain preliminary. Anyone managing ME/CFS or Long-COVID symptoms should work with a qualified healthcare provider.

How is fatigue actually measured in these studies?

Researchers use validated tools like the Fatigue Severity Scale and the SF-36 Physical Function subscale alongside objective tests — six-minute walk distance, grip strength, heart rate variability. Trials that move the needle on both subjective scores and objective function are reporting a stronger signal than those that only show change on a questionnaire.

Why did the first ME/CFS hydrogen water trial not show a benefit?

The initial 28-day trial used a higher daily dose than the trials that followed, and it didn't separate from placebo. Researchers responded by lowering the dose and extending the trial period in subsequent studies — both of which then showed statistically significant improvement. That's a normal part of how a research program refines itself, not a reason to dismiss the later, more positive findings.

Is this the same research as hydrogen water for exercise recovery?

Related, but distinct. The exercise literature — including the 19-trial meta-analysis discussed above — measures fatigue as a short-term response to a workout, typically resolving within a day or two regardless of intervention. The Long-COVID and ME/CFS trials measure fatigue as a persistent, disabling condition that can last months or years and doesn't respond to rest the way exercise fatigue does. Both research threads point toward similar mitochondrial and selective-antioxidant mechanisms, but they're different populations answering different questions, with different trial designs and different endpoints — which is exactly why we've treated them as separate bodies of evidence throughout this article rather than blending them into one claim.

References

Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. 2007. PMID: 17486089.
Hirano SI, Ichikawa Y, Sato B, Takefuji Y, Satoh F. Molecular Hydrogen as a Medical Gas for the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Possible Efficacy Based on a Literature Review. Frontiers in Neurology. 2022. PMID: 35493814.
Tan Y, Xie Y, Dong G, Yin M, Shang Z, Zhou K, Bao D, Zhou J. The Effect of 14-Day Consumption of Hydrogen-Rich Water Alleviates Fatigue but Does Not Ameliorate Dyspnea in Long-COVID Patients: A Pilot, Single-Blind, and Randomized, Controlled Trial. Nutrients. 2024;16(10):1529. PMID: 38794767. DOI: 10.3390/nu16101529.
Friedberg F, Choi D. Hydrogen water and heart rate variability biofeedback as treatments for chronic fatigue syndrome: a pilot randomized trial. Fatigue: Biomedicine, Health & Behavior. 2025;13(3):173-187. DOI: 10.1080/21641846.2025.2504211.
Friedberg F, LeBaron TW. Molecular hydrogen as a treatment for ME/CFS: a mini-review of clinical evidence and mechanistic rationale. Frontiers in Medicine. 2026;13:1760210. DOI: 10.3389/fmed.2026.1760210.
Ostojic SM, et al. Can Molecular Hydrogen Supplementation Reduce Exercise-Induced Oxidative Stress in Healthy Adults? A Systematic Review and Meta-Analysis. Frontiers in Nutrition. 2024. PMID: 38590828.
Milovancev A, Avakumovic J, Drid P, Todorovic N, Stajer V, Ostojic SM. Hydrogen-rich water alleviates inflammation and fatigue in COVID-19: A pilot study. European Journal of Inflammation. 2022;20. DOI: 10.1177/1721727X221094197.

The information in this article is provided for educational purposes only and should not be considered medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before beginning any new wellness practice, especially if you have a medical condition, are pregnant or nursing, or take prescription medications.

Back to blog